1170
X. Fang et al. / Journal of Fluorine Chemistry 129 (2008) 1167–1172
solvent was evaporated in vacuo to give the crude compound 1 as a
4.2.4. (E)-1-Bromo-4-(dimethylamino)-1,1-difluorobut-3-en-2-one
light yellow oil.
(2d)
1H NMR (CDCl3, 500 MHz):
d 7.85 (1H, d, J = 12.2 Hz), 5.25 (1H,
4.1.1. 2-Bromo-1-(4,5-dihydrofuran-3-yl)-2,2-difluoroethanone (1b)
d, J = 12.2 Hz), 3.24 (3H, s), 2.98 (3H, s). 19F NMR (CDCl3, 470 MHz):
1H NMR (CDCl3, 500 MHz):
d
7.67 (1H, t, J = 1.6 Hz), 4.7 (2H, t,
d
À61.4 (2F, s). 13C NMR (CDCl3, 125.8 MHz):
d 180.0 (t, J = 23.9 Hz),
J = 9.8 Hz), 3.0 (2H, t, J = 9.8 Hz). 19F NMR (CDCl3, 470 MHz):
d
157.5, 116.7 (t, J = 320.2 Hz), 86.0, 46.2, 38.1. IR (cmÀ1, KBr): 3447,
2925, 1657, 1585, 1070, 868, 682. EI-MS (m/z): 229 (M + 2+, 23),
227 (M+, 23), 98 (100). HRMS calcd for C6H8ONF2Br: 226.9757,
found: 226.9757.
À59.1 (2F, s). 13C NMR (CDCl3, 125.8 MHz):
d 178.8 (t, J = 27.4 Hz),
164.0 (t, J = 7.0 Hz), 114.4 (t, J = 317.6 Hz), 112.6, 74.4, 27.9. IR
(cmÀ1, KBr): 2929, 1779, 1670, 1594, 1151, 818. EI-MS (m/z): 228
(M + 2+, 6), 226 (M+, 6), 97 (100). HRMS calcd for C6H5O2F2Br:
225.9441, found: 225.9441.
4.2.5. (E)-1-Bromo-1,1-difluoro-4-(pyrrolidin-1-yl)but-3-en-2-one
(2e)
4.1.2. 2-Bromo-1-(5,6-dihydro-4H-pyran-3-yl)-2,2-
1H NMR (CDCl3, 500 MHz):
d
8.05 (1H, d, J = 12.2 Hz), 5.22 (1H,
difluoroethanone (1c)
d, J = 12.2 Hz), 3.62 (2H, t, J = 6.8 Hz), 3.32 (2H, t, J = 7.0 Hz), 2.11–
1H NMR (CDCl3, 500 MHz):
d
8.0 (1H, s), 4.2 (2H, t, J = 5.3 Hz),
2.05 (2H, m), 2.03–1.95 (2H, m). 19F NMR (CDCl3, 470 MHz):
d
2.35 (2H, t, J = 6.3 Hz), 1.99–1.94 (2H, m). 19F NMR (CDCl3,
À61.2 (2F, s). 13C NMR (CDCl3, 125.8 MHz):
d 179.9 (t, J = 23.9 Hz),
470 MHz):
d
À55.9 (2F, s). 13C NMR (CDCl3, 125.8 MHz):
d
181.4 (t,
153.3, 116.8 (t, J = 320.2 Hz), 86.9, 53.7, 48.1, 25.7 7, 25.5. IR (cmÀ1
,
J = 25.2 Hz), 162.8 (t, J = 6.9 Hz), 114.4 (t, J = 318.9 Hz), 109.8, 68.3,
21.3, 19.0. IR (cmÀ1, KBr): 2960, 1678, 1609, 1236, 960. EI-MS (m/
z): 242 (M + 2+, 3), 240 (M+, 3), 111 (100), 83 (24). HRMS calcd for
C7H7O2F2Br: 239.9597, found: 239.9597.
KBr): 2924, 2876, 1662, 1579, 1266, 1077, 939, 863. EI-MS (m/z):
255 (M + 2+, 8), 253 (M+, 8), 174 (12), 124 (100). HRMS calcd for
C8H10ONF2Br: 252.9914, found: 252.9915.
4.3. General procedure for the synthesis of 1,2,3,4-
tetrahydropyrimidines
4.2. General procedure for the synthesis of enaminones
PhNH2 (5 mmol) was added dropwise to the solution of enone
1a (4 mmol) in acetonitrile (10 ml) under stirring at 0 8C. The
mixture was stirred at room temperature for 10 h to complete the
reaction, then the mixture was treated with about 30 ml of water
and extracted with 3 Â 20 ml of ether. The combined organic layer
was washed with saturated brine solution and dried over
anhydrous sodium sulfate. After evaporation of ether, the crude
product was subjected to column chromatography to give the pure
product 2a.
To a solution of enaminone 2a (1 mmol) in DMF (5 ml), were
added primary amines (3 mmol) and 37% formaldehyde
(6.5 mmol). The mixture was stirred at 110 8C for 2–5 h (monitored
by TLC or 19F NMR). After completion of the reaction, the mixture
was cooled to room temperature, diluted with water and extracted
with Et2O. The organic layer was washed with saturated NaCl
solution and dried over anhydrous Na2SO4. The residue obtained
after evaporation of the solvent was purified by flash chromato-
graphy on silica gel.
4.2.1. (Z)-1-Bromo-1,1-difluoro-4-(phenylamino)but-3-en-2-one
4.3.1. 2-Bromo-2,2-difluoro-1-(3-isopropyl-1-phenyl-1,2,3,4-
(2a)
tetrahydropyrimidin-5-yl)ethanone (3a)
1H NMR (CDCl3, 500 MHz):
d
11.7 (1H, br), 7.70–7.65 (1H, m),
7.4 (2H, t, J = 8.0 Hz), 7.2 (1H, t, J = 7.9 Hz), 7.13 (2H, d, J = 7.7 Hz),
5.64 (1H, d, J = 7.5 Hz). 19F NMR (CDCl3, 470 MHz):
À61.8 (2F, s).
13C NMR (CDCl3, 125.8 MHz):
182.4 (t, J = 25.6 Hz), 150.3, 139.5,
130.6, 126.3, 118.0, 115.5 (t, J = 317.8 Hz), 88.9. IR (cmÀ1, KBr):
3248, 1606, 1565, 1300, 1137, 751. EI-MS (m/z): 277 (M + 2+, 20),
275 (M+, 20), 146 (100). HRMS calcd for C10H8ONF2Br: 274.9757,
found: 274.9758.
1H NMR (CDCl3, 500 MHz):
d
7.86 (1H, s), 7.27 (2H, t, J = 7.9 Hz),
6.96 (3H, t, J = 7.9 Hz), 4.69 (2H, s), 4.22 (2H, s), 3.55–3.48 (1H, m),
1.18 (6H, d, J = 6.7 Hz); 19F NMR (CDCl3, 470 MHz):
À52.6 (2F, s);
13C NMR (CDCl3, 125.8 MHz):
176.7 (t, J = 23.7 Hz), 149.4, 148.7,
d
d
d
d
130.0, 122.4, 119.1, 115.7 (t, J = 318.9 Hz), 64.8, 56.4, 46.1, 21.8; IR
(cmÀ1, KBr): 2975, 1585, 1129, 694; EI-MS (m/z): 360 (M + 2+, 13),
358 (M+, 13), 279 (100), 105 (44); HRMS calcd for C15H17O2N2F2Br:
358.0492, found: 358.0492.
4.2.2. (Z)-1-Bromo-1,1-difluoro-4-(isopropylamino)but-3-en-2-one
4.3.2. 2-Bromo-1-(3-tert-butyl-1-phenyl-1,2,3,4-
(2b)
tetrahydropyrimidin-5-yl)-2,2-difluoroethanone (3b)
1H NMR (CDCl3, 500 MHz):
d
10.1 (1H, br), 7.23 (1H, q, J = 7.1 Hz),
1H NMR (CDCl3, 500 MHz):
d 8.04 (1H, s), 7.34–6.98 (5H, m),
5.32 (1H, d, J = 7.1 Hz), 3.65–3.57 (1H, m), 1.32 (6H, d, J = 6.6 Hz). 19
NMR(CDCl3, 470 MHz):
F
4.57 (2H, s), 3.68 (2H, s), 1.14 (9H, s); 19F NMR (CDCl3, 470 MHz):
d
d
À60.6(2F,s). 13CNMR(CDCl3, 125.8 MHz):
À53.9 (2F, s); 13C NMR (CDCl3, 125.8 MHz):
d 176.3 (t, J = 23.7 Hz),
d
180.7 (t, J = 24.7 Hz), 156.6, 116.2 (t, J = 318.1 Hz), 85.2, 51.8, 23.9.
145.8, 142.4, 129.0, 124.8, 118.6, 113.5 (t, J = 318.8 Hz), 62.6, 54.6,
41.0, 26.1; IR (cmÀ1, KBr): 2975, 1578, 1149, 757, 695; EI-MS (m/z):
374 (M + 2)+, 11), 372 (M+, 11), 293 (100), 208 (88), 104 (56); HRMS
calcd for C16H19ON2F2Br: 372.0649, found: 372.0649.
IR (cmÀ1, KBr): 3270, 2977, 1644, 1587, 1139, 1072, 875. EI-MS (m/
z): 243 (M + 2+, 16), 241 (M+, 16), 112 (100), 70 (33). HRMS calcd for
C7H10ONF2Br: 240.9914, found: 240.9914.
4.2.3. (E)-1-Bromo-4-(diisopropylamino)-1,1-difluorobut-3-en-2-
4.3.3. 2-Bromo-1-(1,3-diisopropyl-1,2,3,4-tetrahydropyrimidin-5-
one (2c)
yl)-2,2-difluoroethanone (3c)
1H NMR (CDCl3, 500 MHz):
d
7.89 (1H, d, J = 12.4 Hz), 5.35 (1H,
1H NMR (CDCl3, 500 MHz):
d
7.87 (1H, s), 4.14 (2H, s), 3.64 (2H,
s), 3.62–3.54 (1H, m), 2.96–2.88 (1H, m), 1.32 (6H, d, J = 6.7 Hz),
1.16 (6H, d, J = 6.4 Hz); 19F NMR (CDCl3, 470 MHz):
À52.3 (2F, s);
13C NMR (CDCl3, 125.8 MHz):
174.9 (t, J = 23.4 Hz), 147.2, 114.2
(t, J = 319.1 Hz), 96.9, 61.6, 54.7, 49.8, 43.3, 20.2, 19.2; IR (cmÀ1
d, J = 12.4 Hz), 3.96–3.89 (1H, m), 3.66–3.60 (1H, m), 1.24 (6H, d,
J = 6.8 Hz), 1.21 (6H, d, J = 6.8 Hz). 19F NMR (CDCl3, 470 MHz):
d
d
À61.0 (2F, s). 13C NMR (CDCl3, 125.8 MHz):
d
180.1 (t, J = 23.7 Hz),
d
152.6, 117.1 (t, J = 320.2 Hz), 85.8, 51.0, 49.8, 24.2, 20.2. IR (cmÀ1
,
,
KBr): 3451, 2985, 1563, 1308, 935. EI-MS (m/z): 285 (M + 2+, 15),
283 (M+, 15), 204 (43), 154 (100). HRMS calcd for C10H16ONF2Br:
283.0383, found: 283.0383.
KBr): 2974, 1586, 1134, 690; EI-MS (m/z): 326 (M + 2+, 6), 324 (M+,
6), 245 (100), 174 (26), 124 (26); HRMS calcd for C12H19ON2F2Br:
324.0649, found: 324.0648.